Back to News
Market Impact: 0.2
Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation
Source: newsfilecorp.com
Legal & Litigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities-law violations involving Cellebrite DI Ltd. (NASDAQ: CLBT). The announcement provides no allegations, financial figures, or litigation milestones, but introduces a potential legal and reputational overhang for the company.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CLBT-0.80
More News
- Thousands of Israelis rally against Netanyahu gov’t days before election
- Election posters, mass tourism and property: Israel’s footprint in Cyprus
- Who Israel elects matters, and not just for Israelis
- Is Berkshire Bending the Rules With Bending Spoons?
- Can Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?
- Dan Sullivan vs Dan Sullivan: Why is Trump’s DOJ suing in Alaska?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Research Workflows, Report Format Selection, and Interactive Synthesis
- Can ChatGPT Analyze a 10-K? A Verification Workflow